Skip to main content
Eye logoLink to Eye
. 2014 Mar 13;28(3):365. doi: 10.1038/eye.2014.11

Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study

A Tufail, P J Patel, S Sivaprasad, W Amoaku, A C Browning, M Cole, R Gale, S George, A J Lotery, M Majid, M McKibbin, G Menon, Y Yang, C Andrews, C Brittain, A Osborne
PMCID: PMC3965827

Correction to: Eye (2013), 27, 709–715; doi:10.1038/eye.2013.8; published online 1 March 2013

Since the publication of the above article, it has been noted that a line appeared incorrectly between RETREATMENT WITH RANIBIZUMAB 0.5 mg and YES in Figure 1. In addition, Perform FA and Is leakage evident on FA? incorrectly appeared in separate boxes. The correct figure appears below.

Figure 1.

Figure 1

REPAIR retreatment algorithm.

The authors would like to apologise for this error.


Articles from Eye are provided here courtesy of Nature Publishing Group

RESOURCES